Tag: Risk Evaluation and Mitigation Strategy (REMS)

Palforzia Capsules with Logo

Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...

The company warned that it has had to postpone in-person workshops to train physicians.
Palforzia Capsules with Logo

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

The FDA seeks to mitigate risks associated with treatment by mandating a program that must be followed by patients, prescribers, pharmacies, and healthcare settings.
AAAAI Logo + Palforzia

AAAAI Addresses What Patients and Their Families Need to Know About...

As the FDA moves closer to approving the first food allergy treatment, the AAAAI seeks to help patients and their families understand the realities surrounding OIT.